The company began by using AI to turn terabytes of information into 150-word synopses of patient histories, updated every two ...

Yaron Werber has given his Buy rating due to a combination of factors, primarily the promising progress and outcomes of IO Biotech’s clinical trials. The company’s Phase 3 melanoma study is on ...

The company's CEO, James Dentzer, expressed optimism about the progress of Curis's clinical programs and the potential of emavusertib, particularly given the durable responses observed in salvage ...

The company reported a strong cash position, which is expected to fund operations into late 2026, and emphasized the progress made in its clinical programs, including the completion of enrollment ...

These "never words" can be harmful when spoken by clinicians to patients and families facing serious illness. Seriously ill patients and their families experience intense emotional suffering, and ...

Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus accrued interest totaled approximately $3.7 million. Included in the current ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics ...

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical ...

Checking your hearing has gotten easier with the new hearing test feature in AirPods Pro 2. You can take reliable hearing tests using your iPhone or iPad.

Alex Taylor and Victoria Thain Gioia, founders of vitamin brand Perelel, were brought together by new mom frustrations. Now ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...